Boston Medical Group

What Boston Medical Group does

Boston Medical Group (legal entity: Boston Medical Group Telemedicine LLC, California) is a privately held, founder-operated men's health telemedicine platform serving patients in all 50 US states, with separate clinic operations in Mexico dating back to 1997. The company specializes in treatments for erectile dysfunction, premature ejaculation, hypoactive sexual desire disorder, hormone deficiency, and—more recently—medically supervised weight loss using compounded GLP-1 receptor agonists. The US entity was established in 2004 and pivoted to a nationwide direct-to-consumer telemedicine model in 2024.

The platform delivers care through virtual consultations with US-licensed physicians and ships prescription medications from partner compounding pharmacies directly to patients. Its core product set is anchored by proprietary branded therapies: The Boston Method® diagnostic/treatment protocol, Erexafil™ (a compounded oral combining tadalafil, sildenafil, and apomorphine), Bremetide™ (branded PT-141/bremelanotide for arousal via central nervous system action), ICP/Trimix injections (claimed 98% efficacy regardless of age), Compounded Semaglutide and Tirzepatide, testosterone replacement therapy, and regenerative add-ons such as BostonPRP and Stem-Cell EVS with Exosomes. Technology is centered on a custom telemedicine interface with online booking, prescription management, e-commerce (rx.bostonmedicalgroup.com), and patient intake rather than proprietary AI or clinical decision-support systems.

The business operates on a recurring subscription model with monthly billing at price points of $99 (semaglutide), $149 (tirzepatide), and $190 (physician-led weight loss plans), plus refill-based ED medication subscriptions. Go-to-market is direct-to-consumer via SEO, content marketing, paid social, earned media (LA Times, Chicago Tribune, Fox, ABC, Vogue, CNN, NBC TODAY, GQ), and affiliate/referral channels. The company has 251–500 employees, maintains corporate offices in Huntington Beach and Costa Mesa, California, and is owned by its founders (including CEO/Chairman Allan Hennings and The Boston Method co-developer Daniel Ha), with no disclosed venture capital, private equity, or institutional funding to date.

Name

Boston Medical Group

Legal name

Boston Medical Group Telemedicine LLC

Website

https://bostonmedicalgroup.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

251–500 employees

Short description

Boston Medical Group is a privately held, founder-led telemedicine platform offering men's sexual health and weight loss treatments via licensed physicians in all 50 US states, dispensing proprietary compounded medications (Erexafil, Bremetide, ICP, GLP-1s) on a subscription basis.

Ownership category

akta.pro rank

Product category

Men's Health Telemedicine

NAICS

Offices of Physicians (62111), Offices of Physicians (6211)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Misc Health & Allied Services, Nec (8090), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Men’s Health Prescribing + Pharmacy Delivery Platforms (HLALAIAJ)

akta.pro secondary industries

Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD), Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing (HLALAIAH), Male Reproductive & Sexual Medicine (Andrology) (HLAKAOAD), Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG)

Keywords

• Men's telehealth
• Erectile dysfunction treatment
• Telemedicine prescriptions
• Weight loss medications
• Hormone replacement therapy

Headquarters

HQ city

Chicago

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Technology or R&D, Supply Chain

Revenue model

1. Telemedicine Consultations: Revenue from online medical consultations with licensed physicians for erectile dysfunction, premature ejaculation, weight loss, and other men's health conditions. Consultations are conducted via telemedicine platform with prescription services included.
2. Prescription Medications: Revenue from compounded GLP-1 medications (semaglutide and tirzepatide) for weight loss, and sexual dysfunction medications including ICP injections, oral medications, and peptide therapies. Medications are shipped from licensed pharmacies with monthly subscription pricing.
3. Weight Loss Program: Physician-led weight loss program offering compounded GLP-1 medications with monthly pricing tiers. Includes consultation, medication, and ongoing provider care and support.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Boston Medical Group provides telemedicine-based men's health services, connecting individual male patients nationwide to licensed physicians for online consultations and prescriptions targeting erectile dysfunction, premature ejaculation, weight loss, and low testosterone. Its offering combines remote medical evaluation with proprietary compounded and combination medications (such as Erexafil, Bremetide/PT-141, Trimix, and compounded semaglutide/tirzepatide) dispensed via mail-order pharmacy and delivered directly to the patient's home. The flagship clinical protocol, "The Boston Method," is positioned as a personalized treatment pathway rather than a single one-size-fits-all prescription.

Product overview

Boston Medical Group operates a telemedicine platform providing men's health treatments across multiple specialty areas including erectile dysfunction, premature ejaculation, weight loss, anti-aging, testosterone replacement, hair loss, performance anxiety, and peptide/injection therapies. The core offerings include proprietary branded medications like Bremetide (PT-141) for sexual dysfunction and Erexafil for ED, along with ICP injection therapy (98% effectiveness), Trimix, and compounded GLP-1 weight loss medications (Semaglutide and Tirzepatide). Services are delivered through a physician-led telemedicine model available in all 50 states, supported by The Boston Method protocol for personalized ED treatment.

Differentiator

Problem solved

Functional benefit

Brands

• Erexafil: Compounded oral medication combining Tadalafil, Sildenafil, and Apomorphine for erectile dysfunction treatment.
• Bremetide
• ICP
• The Boston Method

Products and services

• Erexafil
• Bremetide (PT-141)
• Trimix Injectable Therapy
• Intracavernosal Pharmacotherapy (ICP) Program
• Compounded Semaglutide Weight Loss Program
• Compounded Tirzepatide Weight Loss Program
• Testosterone Replacement Therapy
• Premature Ejaculation Treatment
• The Boston Method
• BostonPRP (Platelet-Rich Plasma Therapy)

Quantifiable outcome

• 98% success rate for ICP (intracavernosal pharmacotherapy) treatment regardless of age or medical conditions
• +2 more outcomes

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Six partnerships are on record, tiered core and supporting.

• Licensed PharmaciescoreOthersBoston Medical Group partners with licensed pharmacies for prescription fulfillment. Medications are shipped from these partner pharmacies. The company clearly states it does not manufacture medications and works with FDA-regulated facilities for safety and efficacy.
• Medical Groups and ProviderscoreStrategic or Co-development PartnerBoston Medical Group Telemedicine provides management services to affiliated medical groups and healthcare providers who deliver medical care through the platform. Physicians conduct consultations, make diagnoses, and prescribe treatments.
• LabssupportingTechnology or IntegrationLaboratory services partner supporting medical testing and diagnostics for patient care through the telemedicine platform.
• Marketing and Advertising PartnerssupportingGTM or Marketing PartnerThird-party marketing and advertising partners including Google (DoubleClick), X (formerly Twitter), Facebook Audiences for targeted advertising and analytics. Data sharing arrangements in place for advertising purposes.
• Data Analytics PartnerssupportingTechnology or IntegrationService providers including Google Analytics for website analytics and optimization. Data collection and processing agreements for understanding user interactions.
• BMG-Online PharmacycoreOthersThird-party pharmacies partnered with Boston Medical Group for medication fulfillment. Medications are shipped in non-child-resistant packaging per platform terms.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• LifeMD: Public telehealth company offering direct-to-patient virtual care across weight management (GLP-1), men's health, primary care, and dermatology. Comparable in telemedicine distribution and GLP-1 weight loss subscription offering.
• K Health: AI-driven virtual primary care platform that also offers men's health, weight management (GLP-1), and chronic condition treatment. Comparable telemedicine infrastructure and overlapping weight loss/primary care offering.

Direct peers

• BlueChew: DTC telemedicine platform focused exclusively on erectile dysfunction, offering chewable compounded sildenafil/tadalafil subscriptions. Directly competes in Boston Medical Group's core ED vertical with similar pricing and telemedicine fulfillment.
• Hone Health: Men's longevity and hormone-focused telehealth platform offering testosterone replacement therapy, ED treatment, and weight management. Overlaps with Boston Medical Group's HRT, ED and weight loss offerings via telemedicine.
• Ro (Roman): Direct-to-consumer telehealth platform with a flagship men's sexual health brand (Roman) offering ED, PE, testosterone, and weight loss treatments via telemedicine. Closely comparable product mix, DTC motion, and subscription model.
• Eden (geteden.com): DTC telehealth platform offering prescription ED, PE, and hair loss treatments with similar subscription pricing model and online consultation flow. Directly comparable in DTC men's sexual health positioning.
• Hims & Hers Health: Public, scaled DTC telehealth platform offering prescription ED treatments (sildenafil/tadalafil), weight loss (GLP-1), hair loss, and mental health. Most direct comparable in business model, customer base, and subscription pricing, but with substantially larger scale and capital.

Emerging players

• Marek Health: Telehealth provider focused on men's hormone optimization, testosterone replacement therapy, and ED. Niche player with overlapping men's health/wellness positioning and telemedicine model.
• Alpha Male Plus: Men's sexual health clinic and telemedicine provider offering PRP, peptide, and ED therapies. Comparable in offering combination and regenerative/intracavernosal treatments to Boston Medical Group.

Regional players

• Ageless Men's Health: US men's health clinic network focused on testosterone replacement therapy, ED, and weight loss. Comparable in clinical men's health category, but operates primarily brick-and-mortar clinics versus Boston Medical Group's telemedicine-only model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/thebostonmethod
• YouTubeyoutube.com/BostonMedicalGroupUSA
• Facebookfacebook.com/bostonmmethod
• Instagraminstagram.com/thebostonmethod
• LinkedInlinkedin.com/company/boston-medical-group_2

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Boston Medical Group